Cochrane Systematic Review: Interventions for treating tuberculous pericarditis
Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ
Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ
OBJECTIVES: In people with tuberculous pericarditis, to evaluate the effects on death, life-threatening conditions, and persistent disability of: (1) 6-month antituberculous drug regimens compared with regimens of 9 months or more; (2) corticosteroids; (3) pericardial drainage; and (4) pericardiectomy.
OBJECTIVES: In people with tuberculous pericarditis, to evaluate the effects on death, life-threatening conditions, and persistent disability of: (1) 6-month antituberculous drug regimens compared with regimens of 9 months or more; (2) corticosteroids; (3) pericardial drainage; and (4) pericardiectomy.
Cochrane Systematic Review: Corticosteroids for managing tuberculous meningitis
Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002244. doi: 10.1002/14651858.CD00224...
Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Coc...
OBJECTIVES: To evaluate the effects of corticosteroids as an adjunct to antituberculous treatment on death and severe disability in people with tuberculous meningitis.
OBJECTIVES: To evaluate the effects of corticosteroids as an adjunct to antituberculous treatment on death and severe disability in people with tuberculous meningitis.
Cochrane Systematic Review: Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N
OBJECTIVES: To assess the diagnostic accuracy of Xpert(R) MTB/RIF for pulmonary TB (TB detection), where Xpert(R) MTB/RIF was used as both an initial test replacing microscopy and an add-on test following a negative smear microscopy result.To assess the diagnostic accuracy of Xpert(R) MTB/RIF for rifampicin resistance detection, where Xpert(R) MTB/RIF was used as the initial test replacing culture-based drug susceptibility testing (DST).The populations of interest were adults presumed to have pulmonary, rifampicin-resistant or multidrug-resistant TB (MDR-TB), with or without HIV infection. The settings of interest were intermediate- and peripheral-level laboratories. The latter may be associated with primary health care facilities.
OBJECTIVES: To assess the diagnostic accuracy of Xpert(R) MTB/RIF for pulmonary TB (TB detection), where Xpert(R) MTB/RIF was used as both an initial test replacing microscopy and an add-on test following a negative smear microscopy result.To assess the diagnostic accuracy of Xpert(R) MTB/RIF for rifampicin resistance detection, where Xpert(R) MTB/RIF was used as the initial test replacing culture-based drug susceptibility testing (DST).The populations of interest were adults presumed to have pulmonary, rifampicin-resistant or multidrug-resistant TB (MDR-TB), with or without HIV infection. The settings of interest were intermediate- and peripheral-level laboratories. The latter may be associated with primary health care facilities.
Cochrane Systematic Review: Interventions for treating tuberculous pericarditis
Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ
Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ
OBJECTIVES: In people with tuberculous pericarditis, to evaluate the effects on death, life-threatening conditions, and persistent disability of: (1) 6-month antituberculous drug regimens compared with regimens of 9 months or more; (2) corticosteroids; (3) pericardial drainage; and (4) pericardiectomy.
OBJECTIVES: In people with tuberculous pericarditis, to evaluate the effects on death, life-threatening conditions, and persistent disability of: (1) 6-month antituberculous drug regimens compared with regimens of 9 months or more; (2) corticosteroids; (3) pericardial drainage; and (4) pericardiectomy.
Cochrane Systematic Review: Corticosteroids for managing tuberculous meningitis
Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002244. doi: 10.1002/14651858.CD00224...
Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Coc...
OBJECTIVES: To evaluate the effects of corticosteroids as an adjunct to antituberculous treatment on death and severe disability in people with tuberculous meningitis.
OBJECTIVES: To evaluate the effects of corticosteroids as an adjunct to antituberculous treatment on death and severe disability in people with tuberculous meningitis.
Cochrane Systematic Review: Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N
OBJECTIVES: To assess the diagnostic accuracy of Xpert(R) MTB/RIF for pulmonary TB (TB detection), where Xpert(R) MTB/RIF was used as both an initial test replacing microscopy and an add-on test following a negative smear microscopy result.To assess the diagnostic accuracy of Xpert(R) MTB/RIF for rifampicin resistance detection, where Xpert(R) MTB/RIF was used as the initial test replacing culture-based drug susceptibility testing (DST).The populations of interest were adults presumed to have pulmonary, rifampicin-resistant or multidrug-resistant TB (MDR-TB), with or without HIV infection. The settings of interest were intermediate- and peripheral-level laboratories. The latter may be associated with primary health care facilities.
OBJECTIVES: To assess the diagnostic accuracy of Xpert(R) MTB/RIF for pulmonary TB (TB detection), where Xpert(R) MTB/RIF was used as both an initial test replacing microscopy and an add-on test following a negative smear microscopy result.To assess the diagnostic accuracy of Xpert(R) MTB/RIF for rifampicin resistance detection, where Xpert(R) MTB/RIF was used as the initial test replacing culture-based drug susceptibility testing (DST).The populations of interest were adults presumed to have pulmonary, rifampicin-resistant or multidrug-resistant TB (MDR-TB), with or without HIV infection. The settings of interest were intermediate- and peripheral-level laboratories. The latter may be associated with primary health care facilities.